Company overview

We believe that science-powered innovation creates possibilities. As a privately held, fully-integrated global company, Revance is passionately driven by that philosophy in everything we do. Dedicated to offering a diverse portfolio in aesthetics, skincare, and therapeutics, our science-backed products care for individuals across the generations. By driving innovation beyond convention, we continue to research and develop differentiated products for health, beauty, and wellness.
Founded in 2002
Nashville, Tennessee, USA
688 employees (67 in marketing)
45% recommend to a friend
25% positive business outlook

Salaries

Help build salary transparency at Revance

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

5 open now

Headcount trend

Company growth over the last 12 months

Headcount -0.3% year over year

Funding

Total funding

$1.7B

Last raise

$100M

Post IPO Equity, 2 years ago

Funding history

Mar 2024

Post IPO Equity Revance Therapeutics · $100M

Sep 2022

Post IPO Equity Revance Therapeutics · $200M

Mar 2022

Post IPO Debt Revance Therapeutics · $300M

Feb 2020

Post IPO Debt Revance Therapeutics · $250M

Dec 2019

Post IPO Equity Revance Therapeutics · $110.5M

Jan 2019

Post IPO Equity Revance Therapeutics · $115M

Audience

Monthly website visitors
20.3K
Month over month+3.2%
Quarter over quarter+31.4%
Top sourceDirect (46.2%)
Ad budget per month$0.0
Average search rank60.1
Traffic source mix
Direct
46.2%
Search
42.9%
Social
4.8%
Referral
4.8%
Paid referral
1.3%

LinkedIn followers

Follower count and growth

Total followers

40K

12-mo growth

+25.6%

Monthly growth

+2.7%

News

Links